Longayan, Juanita B.
HRN: 12-09-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2023
METRONIDAZOLE 500MG (TAB)
03/15/2023
03/21/2023
ORAL
500mg
TID
T/C C. Defficile Infection Sec To Recurrent Antibiotic Use
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes